CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Jan. 01, 2023	Jan. 02, 2022	Jan. 03, 2021
Cash flows from operating activities:
Net income	$ 452,263	$ 510,467	$ 491,296
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	80,251	72,923	65,038
Refranchising gain	(21,173)	0	0
Loss on sale/disposal of assets	1,813	1,189	2,922
Amortization of debt issuance costs	5,645	7,509	5,526
Provision for deferred income taxes	253	1,988	14,424
Non-cash equity-based compensation expense	28,709	28,670	24,244
Excess tax benefits from equity-based compensation	(2,169)	(18,911)	(60,364)
Provision for losses on accounts and notes receivable	3,536	659	2,134
Unrealized gain on investments	0	(36,758)	0
Changes in operating assets and liabilities:
Changes in accounts receivable	(6,333)	(8,107)	(33,334)
Changes in inventories, prepaid expenses and other	(17,059)	(9,420)	(24,959)
Changes in accounts payable and accrued liabilities	(36,605)	51,346	68,954
Changes in insurance reserves	1,507	6,216	5,544
Changes in operating lease assets and liabilities	2,174	1,210	2,592
Changes in advertising fund assets and liabilities, restricted	(17,495)	45,225	28,777
Net cash provided by operating activities	475,317	654,206	592,794
Cash flows from investing activities:
Capital expenditures	(87,234)	(94,172)	(88,768)
Proceeds from sale of assets	41,089	16	174
Purchases of franchise operations and other assets	(6,814)	0	0
Purchase of investments	0	(49,082)	(40,000)
Other	(722)	515	(333)
Net cash used in investing activities	(53,681)	(142,723)	(128,927)
Cash flows from financing activities:
Proceeds from issuance of long-term debt	120,000	1,850,000	158,000
Repayments of long-term debt and finance lease obligations	(175,676)	(910,212)	(202,058)
Proceeds from exercise of stock options	3,312	19,682	30,970
Purchases of common stock	(293,740)	(1,320,902)	(304,590)
Tax payments for restricted stock upon vesting	(10,720)	(6,820)	(6,803)
Payments of common stock dividends and equivalents	(157,531)	(139,399)	(121,925)
Cash paid for financing costs	(1,594)	(14,938)	0
Other	0	(244)	0
Net cash used in financing activities	(515,949)	(522,833)	(446,406)
Effect of exchange rate changes on cash	(963)	(316)	761
Change in cash and cash equivalents, restricted cash and cash equivalents	(95,276)	(11,666)	18,222
Cash and cash equivalents, beginning of period	148,160	168,821	190,615
Restricted cash and cash equivalents, beginning of period	180,579	217,453	209,269
Cash and cash equivalents included in advertising fund assets, restricted, beginning of period	161,741	115,872	84,040
Cash and cash equivalents, restricted cash and cash equivalents and cash and cash equivalents included in advertising fund assets, restricted, beginning of period	490,480	502,146	483,924
Cash and cash equivalents, end of period	60,356	148,160	168,821
Restricted cash and cash equivalents, end of period	191,289	180,579	217,453
Cash and cash equivalents included in advertising fund assets, restricted, end of period	143,559	161,741	115,872
Cash and cash equivalents, restricted cash and cash equivalents and cash and cash equivalents included in advertising fund assets, restricted, end of period	$ 395,204	$ 490,480	$ 502,146